• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

State of the industry 2010 spending increase 2010


State of the Industry survey results

"The big unknown is healthcare reform and the impact it will have," says Harvey Sobel, a principal at Buck Consultants in New York and consulting actuary.

Perhaps that uncertainty is why a majority of respondents stuck to historical patterns in predicting spending for 2010. In the poll, 27.6% predicted overall spending would rise 5% to 8% next year while 25.8% forecast a spending increase of 8% to 12%. The mean response was 9.3%.

Healthcare reform that brings coverage to all or some of the nation's estimated 46 million uninsured almost certainly would increase spending, but the major impact might not be felt until 2011, Sobel says.

In general, overall spending indicates other trends, such as premium increases and increases in out-of-pocket spending.

Some of the spending increase next year will be attributable to the new parity requirement for coverage of mental illnesses and substance-abuse disorders. There are exemptions, but in general, the regulations call for financial parity, treatment parity and network parity beginning Jan. 1, 2010.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.